SCHEMBL25815485

SCHEMBL25815485

Cc1cc(C)cc(-c2cccc(-c3cccc(-c4cc(C)cc(CO)c4)c3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.46
MAP2K4 P45985 1/20 0.41
ACMSD Q8TDX5 1/20 0.39
IDH1 O75874 2/20 0.39
DHODH Q02127 2/20 0.38
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
GGPS1 O95749 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
ACHE P22303 1/20 0.36
PTPN5 P54829 1/20 0.36
CDK8 P49336 1/20 0.36
IKBKB O14920 1/20 0.35
CHUK O15111 1/20 0.35
PTGER4 P35408 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2E1 P05181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20215168 0.86 IDH1 (0.46) PRKCIMAP2K4ACMSDIDH1DHODH
SCHEMBL29628933 0.81 ACHE (0.53) DHODHRXRARXRBACHECYP1A1
SCHEMBL14960038 0.80 PRKCI (0.58) PRKCIMAP2K4ACMSDCHRNB4CHRNA3
SCHEMBL23750141 0.79 PRKCI (0.67) PRKCIMAP2K4ACMSDDHODHCHRNB4
SCHEMBL92965 0.78 ACHE (0.48) IDH1ACHE
SCHEMBL20215166 0.77 KDR (0.52) DHODHPTGER4CYP4F2CYP4A11
SCHEMBL3394161 0.76 CYP1A1 (0.53) PRKCIMAP2K4ACMSDIDH1ACHE
SCHEMBL21973519 0.74 TSHR (0.55) PRKCIACMSDIDH1RXRARXRB
SCHEMBL14036342 0.74 MAOA (0.52) IDH1DHODHRXRARXRBACHE
SCHEMBL27948002 0.74 MAOA (0.52) IDH1DHODHRXRARXRBACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM PRKCI 2865/4885MAP2K4 4034/4885ACMSD 1898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.